Clinical Trial Update: Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis

View source ↗

Summary

Pfizer conducted a clinical trial evaluating etanercept for ankylosing spondylitis. The study is completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Ankylosing Spondylitis | Status: COMPLETED | Results posted: 2015-05-12